Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,598,853
-
Share change
-
+3,785,175
-
Total reported value
-
$269,786,514
-
Price per share
-
$19.84
-
Number of holders
-
57
-
Value change
-
+$74,050,623
-
Number of buys
-
41
-
Number of sells
-
10
Institutional Holders of G1 THERAPEUTICS INC - COM (GTHX) as of Q4 2017
As of 31 Dec 2017,
G1 THERAPEUTICS INC - COM (GTHX) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,598,853 shares.
The largest 10 holders included
FMR LLC, FRANKLIN RESOURCES INC, WELLINGTON MANAGEMENT GROUP LLP, Cormorant Asset Management, LLC, Vanguard Group Inc, BlackRock Inc., EMERALD ADVISERS INC/PA, Boxer Capital, LLC, EMERALD MUTUAL FUND ADVISERS TRUST, and Hillhouse Capital Management, Ltd..
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.